Lipids in Health and Disease

<p><em>Lipids in Health and Disease</em> is an open access, peer-reviewed journal that publishes articles on all aspects of lipids, such as their interaction with proteins and their pharmacological, (bio)chemical, and molecular effects at the organismal level. We are also interested in molecular toxicological investigations related to lipids and natural products that can interact with various aspects of lipids in health and disease. The synthesis and actions of new lipid compounds and enzyme systems involved in lipid synthesis and metabolism are of interest.</p> <p><em>Lipids in Health and Disease</em> invites submissions from all scientists, health care professionals, and physicians in all areas of lipids. Lipids are defined herein in their broadest sense and include:</p> cholesterol triacylglycerols fatty acids phospholipids sphingolipids glycosphingolipids remnant cholesterol inositol lipids sterols and oxysterols second messenger lipids (such as diacylglycerol and ceramide) storage and bioactive lipid forms lipid mediators (e.g., eicosanoids, resolvins) lipid‒protein conjugates structural lipids relevant to membranes and signaling pathways <p>The journal publishes research that investigates and defines the role of lipids in various physiological and pathological processes including, but not limited to:</p> enzymes and synthetic machinery involved in the metabolism of lipids in cells and tissues lipid transport energy storage and metabolism structural components of cell membranes hormone synthesis cellular signaling brain and nervous system function nutrient absorption and transport thermoregulation and protection cardiovascular diseases obesity and metabolic syndrome diabetes mellitus neurodegenerative diseases inflammatory and autoimmune diseases cancer liver diseases infectious diseases kidney disease pulmonary diseases musculoskeletal disorders reproductive and endocrine disorders dermatological diseases eye diseases the gut‒brain axis and microbiota-linked disorders <br/> <p>The journal particularly welcomes:</p> Cutting-edge studies in emerging areas of lipid research, including lipidomics, spatial lipidomics, and the integration of lipid data with other omics technologies such as genomics, transcriptomics, proteomics, and metabolomics, to identify novel lipid biomarkers and therapeutic targets. Research exploring the roles of lipids in immunometabolism, all areas of immunity, and the resolution of inflammation is especially encouraged. Research on lipid-based nanocarriers, including lipid nanoparticles (LNPs), and other lipid-derived delivery systems used in gene therapy, mRNA vaccines, and advanced drug delivery applications. Studies investigating lipid dysregulation in aging, cellular senescence, and longevity Research employing computational modeling and artificial intelligence (AI) to predict lipid interactions, functions, and disease associations. Submissions addressing the influence of dietary lipids, food-derived bioactive lipids, nutraceuticals, and environmental exposures on lipid metabolism and related health outcomes are strongly supported. <p>In particular, the journal seeks to bridge the gap between fundamental research and clinical application by highlighting studies that clarify the role of lipids in disease mechanisms, diagnostics, and therapeutic strategies.</p>

List of Papers (Total 5,199)

Joint association of different insulin resistance-related indices and moderate-to-vigorous physical activity with risk of cardiometabolic disease and multimorbidity: insights from the UK Biobank prospective cohort study

Insulin resistance (IR)-related indices and moderate-to-vigorous physical activity (MVPA) were independent predictors for cardiometabolic disease (CMD) and multimorbidity (CMM), but their combined effect is unclear. We aimed to investigate their joint effect on incident CMD and CMM. This study was conducted from the UK Biobank accelerometer sub-study. The IR-related indices...

Lipid-lowering therapy in Switzerland: time trends in utilization and cost, 2015–2023

National utilization trends of lipid-lowering therapy (LLT) have been studied for a subgroup of patients insured in Switzerland between 2013 and 2019. In 2019, the European Society of Cardiology (ESC) released new guidelines on the management of dyslipidaemia providing novel cholesterol targets. Additionally, new lipid-lowering compounds and combination drugs have been introduced...

Dysbetalipoproteinaemia in genetically predisposed Ghanaians

Dysbetalipoproteinaemia (dysβ) is a genetic lipid disorder characterised by accumulated remnant lipoproteins, leading to mixed hyperlipidaemia and increased cardiovascular risk. It is primarily associated with apolipoprotein E (apoE) ε2/ε2 homozygosity, although variants, such as arginine 145 cysteine (R145C), may also contribute. In sub-Saharan Africa, including Ghana, dysβ...

Associations between six cumulative insulin resistance-related indices and incident stroke in individuals with different glucose regulation statuses: a national cohort study in China

Stroke continues to be a predominant contributor to morbidity and mortality, with insulin resistance (IR) recognized as a significant risk factor. The predictive utility of cumulative IR-related indices for assessing stroke risk across varying glucose regulation statuses remains ambiguous. The present study investigated the associations between six cumulative IR-related indices...

Atherogenic index of plasma and subclinical vascular disease: predictive value for coronary and carotid atherosclerosis in a health screening population

To evaluate the predictive value of the atherogenic index of plasma (AIP) for coronary artery calcification (CAC), carotid atherosclerosis (CA), and their coexistence, and to develop a multidimensional risk prediction model to optimize early cardiovascular disease (CVD) screening. A total of 32,992 individuals who underwent carotid intima–media thickness (CIMT) measurement and...

Cardiovascular endpoints and psychosocial challenges of lipoprotein(a) of 5726 participants in the ELITE-study over 5 years

Lipoprotein(a) [Lp(a)] is a known independent risk factor for cardiovascular disease, yet awareness and management remain limited. The psychosocial implications of elevated Lp(a)-levels have been poorly characterized. To compare cardiovascular outcomes and cardiovascular risk factor (CVRF) modification in individuals with normal vs. elevated Lp(a) levels, and to assess the impact...

Associations of lipoprotein subclasses with all-cause and cardiovascular mortality: results of two independent cohorts with a 20 year follow-up

Currently total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are used in clinical practice to estimate future cardiovascular risk. We assessed whether other lipoprotein subclasses also contribute to cause-specific and all-cause mortality in the general population. Two independent cohorts of the Study of Health in Pomerania (SHIP-START and SHIP-TREND) were used...

The association between plasma omega-3 fatty acids and suicidal ideation/self-harm in the United Kingdom Biobank

Self-harm is a significant public health concern, with increasing prevalence globally. Omega-3 fatty acids (FAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known for their health benefits, including potential mental health improvements. This study explores the association between omega-3 FAs and self-harm behaviors using data from the UK Biobank...

Triglyceride-glucose index and postoperative delirium: a retrospective study exploring a lipid-related marker in neuropsychiatric risk stratification after gastric surgery

Delirium is a common neuropsychiatric complication following major gastrointestinal surgery and is associated with poor postoperative outcomes. Patients undergoing gastric surgery often experience significant metabolic stress and insulin resistance, which may contribute to delirium. The triglyceride-glucose (TyG) index is a simple surrogate marker of insulin resistance, but its...

Joint analysis of atherogenic index of plasma clusters and a body shape index trajectories in incident stroke risk

As emerging biomarkers for stroke risk, the clinical value of the atherogenic index of plasma and a body shape index has gained increasing attention. However, current research on their combined use for stroke risk stratification remains limited. This study aims to analyze the combined effects of Atherogenic Index of Plasma (AIP) and A Body Shape Index (ABSI) trajectories to...

Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study

Effective lipid management is critical for secondary stroke prevention, however, many patients fail to achieve target low-density lipoprotein cholesterol (LDL-C) levels with statin monotherapy. This study evaluated the real-world effectiveness and safety of switching from statin monotherapy to rosuvastatin plus ezetimibe combination therapy (REZ) in patients with stroke. This...

Association of the uric acid-to-high-density lipoprotein cholesterol ratio with vitamin D deficiency in postmenopausal women: evidence from NHANES 2005–2016

The relationship between vitamin D deficiency and the uric acid-to-high-density lipoprotein cholesterol ratio (UHR) in postmenopausal women remains unclear. This study aims to investigate the association between these variables and to evaluate the potential interaction between UHR and waist circumference (WC). Data from 5,155 postmenopausal women who participated in the National...

Interactions between lipid droplets and mitochondria in metabolic diseases

Metabolic diseases, a major challenge in global public health, are commonly characterized by insulin resistance, lipid metabolism disorders, and mitochondrial dysfunction, and their pathological processes are often accompanied by the abnormal accumulation of lipids in metabolically active tissues such as the liver, heart, and skeletal muscle. Recently, lipid droplets and...

Imidazole propionate ameliorates lipid metabolism in adipocytes to attenuate high-fat diet-induced obesity via PPAR signaling pathway

Obesity is a global health concern linked to metabolic disorders and gut microbiota dysbiosis, particularly under high-fat diet (HFD) conditions. This study explores the role of imidazole propionate (ImP), a histidine-derived microbial metabolite, in regulating lipid metabolism and the development of obesity. Male C57BL/6 mice were fed either a chow diet or HFD for 15 weeks...

Preoperative plasma ceramide profiling coupled with machine learning accurately predicts recurrence of hepatocellular carcinoma after resection

Accurate stratification of recurrence risk after curative resection remains a critical challenge in the management of hepatocellular carcinoma (HCC). Dysregulated ceramide (CER) metabolism has been implicated in HCC progression and relapse. This paper evaluates whether preoperative plasma CER profiling coupled with machine learning (ML) enhances the risk prediction of HCC...

Triglyceride glucose-waist circumference dynamics and cardiovascular risk: a national longitudinal study

Cardiovascular disease (CVD) has been documented to be related with the triglyceride glucose (TyG) index. However, limited research has explored the change in the triglyceride glucose-waist circumference (TyG-WC) index in relation to CVD, particularly among individuals with prediabetes and diabetes. Thus, this longitudinal analysis aimed to investigate the association between...

Remnant cholesterol, low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: a cohort study

Recent studies highlighted the independent role of remnant cholesterol (RC) on the risk of atherosclerotic cardiovascular disease (ASCVD). We explored interrelationships among low-density lipoprotein cholesterol (LDL-C), RC, and ASCVD in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). Analyzing 25,418 MASLD and 57,501 non-MASLD ASCVD- free...

Fat mass index is associated with altered platelet fatty acid composition, oxidative stress, and inflammation

Obesity and excessive body fat lead to metabolic and inflammatory disturbances. The fat mass index (FMI) has recently been recognized as a more sensitive measure of obesity than body mass index (BMI). Therefore, we investigated the relationship between higher FMI and alterations in platelet phospholipid fatty acid (FA) composition, oxidative stress, and inflammation. Cross...

Predictive value of systemic inflammation response index for atherosclerotic cardiovascular disease risk in patients with hypercholesterolemia: a machine learning study with dual-cohort validation

Residual cardiovascular risk persists in patients with hypercholesterolemia despite lipid-lowering therapy, underscoring the importance of inflammation in ASCVD development. This study evaluated the relationship between Systemic Inflammation Response Index (SIRI) (a composite biomarker derived from neutrophil, monocyte, and lymphocyte counts) and ASCVD in patients with...

Body roundness index as a novel anthropometric predictor of sarcopenia in patients with cancer: a bicontinental cohort study across Chinese and American populations

Sarcopenia, the progressive depletion of skeletal muscle mass and strength, worsens daily living outcomes and survival in individuals diagnosed with cancer. It arises from complex interactions between primary malignancy, antineoplastic interventions, and treatment-related sequelae, making early risk assessment a clinical priority. The body roundness index (BRI), an anthropometric...

Central obesity measured by waist-to-hip ratio independently predicts crohn’s disease risk: a prospective cohort study

This study evaluated associations between several obesity indicators and the risks of Crohn’s disease (CD) and ulcerative colitis (UC), the two principal clinical phenotypes of inflammatory bowel disease (IBD). Data from 479,590 UK Biobank participants (mean age ± standard deviation: 56.5 ± 8.09 years; 54.5% female) were analyzed. Participants were classified based on waist...

Insulin resistance surrogates predict major adverse cardiovascular events in patients with heart failure with preserved ejection fraction and chronic kidney disease: a retrospective cohort study

Heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD) frequently coexist and portend a poor prognosis. Insulin resistance (IR) is implicated in cardiorenal pathophysiology, but practical surrogate IR indices for predicting risk in this high-risk and understudied population are lacking. This study evaluated and compared the prognostic value of...

Skeletal muscle density mediates the relationships of monocyte-lymphocyte ratio, apolipoprotein A1/HDL, and alkaline phosphatase with thoracic aortic calcification: a multicenter study in patients undergoing maintenance dialysis

To investigate the associations of systemic inflammation, lipid metabolism, bone metabolism markers, and muscle quality with thoracic aortic calcification (TAC) in patients undergoing maintenance dialysis. This multicenter cross-sectional research involved 1916 patients aged 18–80 years who underwent maintenance dialysis across four tertiary hospitals in China between January...